Seeking Alpha

More on Mast Therapeutics Q1 results

Net loss: $6.4M (-14.3%), R&D: $4.3M (+24%), SG&A: $2.3M (+7%).

Quick assets at quarter end: $49.6M.

Working capital: $44.4 (+9.1%).

25 mutual funds have positions, down from 26 a year ago.

(MSTX +1.4%)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs